15:55 Feb 26

AstraZeneca Pharma India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
8849.00
-20.00 (-0.23%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

AstraZeneca Pharma India Ltd. Financials

AstraZeneca Pharma India Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
8849.00
-20.00 (-0.23%)
15:55 Feb 26
Quality
image/svg+xml

61/100
High Financial Strength

Valuation
image/svg+xml

26/100
Expensive Valuation

Technical

44/100
Technically Neutral

Strength

5

Weakness

3

Opportunity

1

Threats

0

15.02 %

ROE %

7.62 %

ROA %

80.36

EPS

308.14

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
813.56 805.6 1002.97 1295.53 1716.29
Operating Expenses +
678.09 719.42 837.85 1111.08 1462.32
Raw Material
292 297.49 408.84 628.33 1295.95
Increase Decrease in Cost
2.95 14.47 -48.86 -33.77 -332.94
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
219.54 230.21 259.1 241.45 257.44
Miscellaneous Expenses
553.08 593.01 867.69 1273.69 2259.51
Operating Profit
135.47 86.18 165.12 184.45 253.97
Other Income
12.84 14.76 26.1 34.8 40.63
Depreciation
20.13 16.95 16.26 14.94 39.99
Interest
1.09 0.95 0.63 1.2 1.46
Profit before tax and exceptio..
127.09 83.04 174.33 203.11 253.15
Exceptional Items
0 0 -40.23 16.43 -96.79
PBT
127.09 83.04 134.1 219.54 156.36
Provision for Taxation
33.79 21.44 34.81 58.03 40.62
Net Profit
93.3 61.6 99.29 161.51 115.74
NET Profit after MI
0 0 0 0 0
EPS
37.3 24.6 39.7 64.6 46.3
Operating Profit Margin (%)
16.65 10.7 16.46 14.24 14.8
Net Profit Margin (%)
11.47 7.65 9.9 12.47 6.74

AstraZeneca Pharma India Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 75.00 75.00 75.00 75.00 75.00 75.00
FII 2.70 2.70 3.00 2.90 2.90 2.90
Public 5.60 5.30 4.60 4.60 5.20 5.10
Others 16.70 17.00 17.40 17.50 16.90 17.00
Shareholder Shares Holding %
Download Our App On: